About us

In 2013, the Positivrat Schweiz, the Patient Advocates for Cancer Research and Treatment (PACRT), the Swiss Clinical Trial Organisation (SCTO) and the University Hospital Basel (USB) created an informal network of stakeholders in Switzerland interested in medicines research and development and patient involvement. Shortly thereafter, the team began to collaborate closely with Swissmedic, the Swiss Agency for Therapeutic Products.

In 2014, representatives from other patient organisations and the pharmaceutical industry joined the network and together several public events were organised to raise awareness for EUPATI in Switzerland.

The association EUPATI CH, the Swiss national platform of EUPATI, was founded in 2016 with the aim of institutionalizing patient involvement in drug research and development in Switzerland. National platforms exist in 23 European countries.